US Patent 7855215 Cyclic diaryl ureas suitable as tyrosine kinase inhibitors

Patent 7855215 was granted and assigned to Novartis on December, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

78552150

Patent Inventor Names

Carole Pissot Soldermann0

Guido Bold0

Giorgio Caravatti0

Paul W Manley0

Pascal Furet0

Andrea Vaupel0

Andreas Floersheimer0

Date of Patent

December 21, 2010

Patent Application Number

115756010

Date Filed

September 27, 2005

Patent Primary Examiner

‌

Kahsay T. Habte

Patent abstract

The invention relates to novel compounds of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7855215 Cyclic diaryl ureas suitable as tyrosine kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API